Meet the Staff
Mark Lim, PhD, PMP
Vice President, Research, Discovery, and Innovation
Dr. Lim oversees the strategic priorities of both KHI and KidneyX. He is also deeply involved in initiatives within
ASN that continue to push the barrier of current treatment options for people living with kidney diseases.
Director, Research, Discovery, and Innovation
Ms. Galley is responsible for the operational oversight of both KHI and KidneyX. She leads the governance initiatives for the
KHI Board of Directors, the KidneyX Steering Committee, and the KHI PFPC.
Program Manager, Kidney Health Initiative
Ms. Malley oversees the strategy for the entire KHI portfolio including the Board of Directors. She maintains a strong relationship
with the FDA and our member organizations to foster collaboration that continues to push the envelope in the kidney space.
Artificial Kidney Specialist, Research, Discovery, and Innovation
Mr. Cahill is responsible for KHI's project focused on the artificial kidney. His work has allowed KHI to survey the patient and patient care
community about their perspectives surrounding xenotransplantation and artificial kidneys. In 2022, his work will include a landscape
analysis and recommendations for industry.
Program Associate, Research, Discovery, and Innovation
Ms. Martin is responsible for the administrative support for KHI. She works closely with all staff members to ensure efficiency and
organization within KHI.
Administrative Associate, Research, Discovery, and Innovation
Ms. Wilson is responsible for the administrative support for KHI. She works closely with all staff to provide support and scheduling
for KHI meetings and events. She is also the staff liaison for Patient and Family Partnership Council.